Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hiroshi Uchigata"'
Autor:
Yasutoshi Sakamoto, Hideaki Bando, Yoshiaki Nakamura, Hiromi Hasegawa, Takako Kuwaki, Wataru Okamoto, Hiroya Taniguchi, Yoshihiro Aoyagi, Izumi Miki, Hiroshi Uchigata, Naomi Kuramoto, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu
Publikováno v:
Clinical colorectal cancer.
Utilizing real-world data (RWD) for effective clinical implementation is becoming more and more appealing as the cost of drug development rises, especially for patients with rare diseases and rare molecular subtypes for whom conducting randomized con
Autor:
Yasutoshi Sakamoto, Hideaki Bando, Yoshiaki Nakamura, Hiromi Hasegawa, Takako Kuwaki, Wataru Okamoto, Hiroya Taniguchi, Yoshihiro Aoyagi, Izumi Miki, Hiroshi Uchigata, Naomi Kuramoto, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu, Sakamoto, Yasutoshi, Bando, Hideaki, Nakamura, Yoshiaki, Hasegawa, Hiromi, Kuwaki, Takako, Okamoto, Wataru
Publikováno v:
Clinical Colorectal Cancer; Mar2023, Vol. 22 Issue 1, p45-52, 8p
Autor:
Yoshito Komatsu, Naomi Kuramoto, Satoshi Yuki, Hiroshi Uchigata, Yasutoshi Sakamoto, Justin I. Odegaard, Satoshi Fujii, Hiromichi Ebi, Yoshiaki Nakamura, Kentaro Sawada, Steve Olsen, Seiko Matsuda, Kana Kitajima, Hiroya Taniguchi, Wataru Okamoto, Takashi Asakawa, Taito Esaki, Nozomu Fuse, Atsushi Ohtsu, Toshiki Masuishi, Akihiro Sato, Tomohiro Nishina, Makoto Fukui, Takayuki Yoshino, Shogo Nomura, Ken Kato, Takeshi Kato
Publikováno v:
Nature Medicine
The applicability of circulating tumor DNA (ctDNA) genotyping to inform enrollment of patients with cancer in clinical trials has not been established. We conducted a phase 2 trial to evaluate the efficacy of pertuzumab plus trastuzumab for metastati
Autor:
Etsuko Goto, Yuji Fujikawa, Nagayoshi Takashi, Hiroshi Kataoka, Yo Hosaka, Tsuyoshi Tateishi, Hiroshi Uchigata
Publikováno v:
Zairyo-to-Kankyo. 65:59-66